No patient left behind : The promise of immune priming with epigenetic agents

Autor: Carter, Corey A., Oronsky, Bryan T., Roswarski, Joseph, Oronsky, Arnold L., Oronsky, Neil, Scicinski, Jan, Lybeck, Harry, Kim, Michelle M., Lybeck, Michelle, Reid, Tony R.

Checkpoint inhibitors, monoclonal antibodies that inhibit PD-1 or CTLA-4, have revolutionized the treatment of multiple cancers. Despite the enthusiasm for the clinical successes of checkpoint inhibitors, and immunotherapy, in general, only a minorit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1593::ae2a5e703a0a3782d4dc013481080f44
http://hdl.handle.net/10138/228981

RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological Tumor.

Autor: Brzezniak, Christina, Oronsky, Bryan, Trepel, Jane, Summers Jr., Thomas A., Cabrales, Pedro, Lee, Min-Jung, Day, Regina, Jha, Saheli, Caroen, Scott, Zeman, Karen, Ferry, Lindsey, Harmer, Cindy, Oronsky, Neil, Lybeck, Michelle, Lybeck, Harry E., Brown, James F., Reid, Tony R., Carter, Corey A.

Publikováno v: Case Reports in Oncology; Jan-Apr2017, Vol. 10 Issue 1, p276-280, 5p

A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001.

Autor: Oronsky, Bryan, Caroen, Scott, Zeman, Karen, Quinn, Mary, Brzezniak, Christina, Scicinski, Jan, Cabrales, Pedro, Reid, Tony R., Trepel, Jane B., Abrouk, Nacer D., Larson, Christopher, Oronsky, Arnold, Lybeck, Harry E., Day, Regina M., Carter, Corey A.

Publikováno v: Clinical Medicine Insights: Oncology; 2016, Issue 10, p105-108, 4p

No patient left behind: The promise of immune priming with epigenetic agents.

Autor: Carter CA; Walter Reed National Military Medical Center, Murtha Cancer Center, Bethesda, MD, USA., Oronsky BT; EpicentRx, Inc., San Diego, CA, USA., Roswarski J; Walter Reed National Military Medical Center, Murtha Cancer Center, Bethesda, MD, USA., Oronsky AL; InterWest Partners, Menlo Park, CA, USA., Oronsky N; CFLS Data, San Jose, CA, USA., Scicinski J; EpicentRx, Inc., San Diego, CA, USA., Lybeck H; University of Helsinki, Department of Physiology, Helsinki, Finland., Kim MM; University of Michigan, Department of Radiation Oncology, Ann Arbor, MI, USA., Lybeck M; EpicentRx, Inc., San Diego, CA, USA., Reid TR; University of California San Diego, Moores Cancer Center, La Jolla, CA, USA.

Publikováno v: Oncoimmunology [Oncoimmunology] 2017 Aug 30; Vol. 6 (10), pp. e1315486. Date of Electronic Publication: 2017 Aug 30 (Print Publication: 2017).

RRx-001 in Refractory Small-Cell Lung Carcinoma: A Case Report of a Partial Response after a Third Reintroduction of Platinum Doublets.

Autor: Carter CA; Walter Reed National Military Medical Center, Murtha Cancer Center, Bethesda, Md., USA., Oronsky BT; EpicentRx Inc., Mountain View, Calif., USA., Caroen SZ; EpicentRx Inc., Mountain View, Calif., USA., Scicinski JJ; EpicentRx Inc., Mountain View, Calif., USA., Degesys A; Walter Reed National Military Medical Center, Murtha Cancer Center, Bethesda, Md., USA., Kim MM; Department of Radiation Oncology, University of Michigan, Ann Arbor, Mich., USA., Oronsky AL; InterWest Partners, Menlo Park, Calif., USA., Lybeck H; Department of Physiology, University of Helsinki, Helsinki, Finland., Cabrales P; Department of Bioengineering, University of California San Diego, La Jolla, Calif, USA., Oronsky N; CFLS Data, Mountain View, Calif., USA., Reid T; Moores Cancer Center, University of California San Diego, La Jolla, Calif., USA., Roswarski J; Walter Reed National Military Medical Center, Murtha Cancer Center, Bethesda, Md., USA., Brzezniak C; Walter Reed National Military Medical Center, Murtha Cancer Center, Bethesda, Md., USA.

Publikováno v: Case reports in oncology [Case Rep Oncol] 2016 Mar 11; Vol. 9 (1), pp. 171-6. Date of Electronic Publication: 2016 Mar 11 (Print Publication: 2016).